Related Experiment Video

Updated: Sep 10, 2025

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

11.0K

Enhancing Standardization in the Pediatric Management of Hereditary Polyposis Syndromes

Luigi Ricciardiello1, Y Nancy You2

  • 1Department of Gastroenterology and Hepatology, The University of Texas at MD Anderson Cancer Center, Houston, Texas.

Cancer Prevention Research (Philadelphia, Pa.)
|August 22, 2025
PubMed

Insights

Hereditary polyposis syndromes require better pediatric care. This study proposes standardized protocols, multidisciplinary centers, and research to improve management and reduce cancer risk in children.

Area of Science:

  • Genetics and Oncology
  • Pediatric Medicine

Background:

  • Hereditary polyposis syndromes (HPS) are inherited conditions with a high risk of malignancy.
  • Current management includes genetic testing, surveillance, and surgery, but lacks pediatric-specific standardization.

Purpose of the Study:

  • To propose targeted solutions for improving pediatric hereditary polyposis syndrome care.
  • To address the lack of standardization in managing HPS in children.

Main Methods:

  • Review of current management practices for HPS.
  • Proposal of pediatric-focused protocols and decision-support tools.
  • Recommendations for multidisciplinary centers, psychosocial support, and transition programs.
  • Emphasis on genotype-phenotype research and chemoprevention trials.

Main Results:

  • Identification of key areas for improvement in pediatric HPS care.
  • Development of a framework for standardized, evidence-based management.
  • Highlighting the need for coordinated efforts and investment in research.

Conclusions:

  • Standardized, multidisciplinary, and equitable care is crucial for pediatric HPS.
  • Implementing proposed solutions can enhance lifelong management and reduce malignancy risk.
  • Further research and clinical trials are essential for advancing pediatric HPS care.

More Related Videos

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

848

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
212
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
223
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
293
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
201